Mol Aspects Med 30:112 Frade J, Pope S, Schmidt M, Dringen R, Barbosa R, Pocock J, Laranjinha J, Heales S (2008) Glutamate induces release of glutathione from cultured rat astrocytes - a possible neuroprotective mechanism
Approved Nanomedicines Between 2012 and 2024, the approval of nanomedicines for RA has been limited (Table 1), with most advancements remaining in preclinical or clinical trial phases
Specifically during this time, melanocyte-stimulating hormone (MSH), estrogen, and progesterone increase
Both citicoline and montelukast have demonstrated favorable safety profiles, reinforcing their potential as promising therapeutic agents for ASD
Scheen AJ, Lefbvre PJ